Egetis Therapeutics AB (EGTX.ST)

P/S ratio as of July 2026 (TTM): 46.9

According to Egetis Therapeutics AB's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 12.0. At the end of 2026 the company had a P/S ratio of 34.1.

P/S ratio history for Egetis Therapeutics AB from 2011 to 2026

PS ratio at the end of each year

Year	P/S ratio	Change
2026	34.1	-2.02%
2025	34.8	-33.56%
2024	52.4	79.47%
2023	29.2	-55.88%
2022	66.2	139.4%
2021	27.6	-19.71%
2020	34.4	165.81%
2019	12.9	-50.5%
2018	26.2	-59.68%
2017	64.9
2016	N/A
2015	N/A
2014	N/A
2013	N/A
2012	N/A	-100%
2011	0.7404

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Egetis Therapeutics AB (EGTX.ST)